FDA warns Dexcom over 2 site deficiences

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and Mesa, Ariz. 

Read the full post on Becker's Hospital Review | Healthcare News & Analysis